Current Market Information

Last Trade Price (LTP) 10.60 Last Trade Date 08 October, 2026 Change -9.40 % Open Price 11.70 Day's Range 10.60 - 10.60     Total Trade 1 Total Volume 1 Close Price 10.60 Yesterday Close Price 11.70 Market Capital in BDT (mn) 987.207

Contact Information

Designation Name Mobile Number Email Chairman Asif Iqbal Chowdhury MD Faria Binta Alam Company Secretary Suman Sarker 01713254482 cs.advent2007@gmail.com Office Address Rupayan Karim Tower, Level # 10 Road, 80-Kakrail, VIP Road, Ramna, Dhaka-1000 Phone : 02-9185352 Fax : 02-9185351 Email : Website : http://www.adventpharmabd.com Factory Address Plot # B 50-54 BSCIC Industrial Estate, Kalampur, Dhamrai, Dhaka-1351.

Basic Information

Authorized Capital in BDT* (mn) 1,000.00 Paid-up Capital in BDT* (mn) 931.33 Face Value 10 Paid up Share 93132732     Market Lot 1 Sector PHARMA & CHEMICALS Market Category Z

Other Information

Listing Year 2018 Debut Trade Date 12 April, 2018 Type of Instrument     52 Week's Range 10.50 - 16.90 Year End 30 June Reserve / Surplus(mn) 538.68 Remarks Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 31-Aug, 2026 30.02 0 12.78 1 56.2 As on 31-Jul, 2026 30.02 0 12.79 1 56.19 As on 31-May, 2026 30.02 0 11.76 1.01 57.21 As on 30-Jun, 2026 (year ended) 30.02 0 12.6 1 56.38     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Jan 26, 2026 A- ST-3 Stable Jul 25, 2027 Alpha Credit Rating Limited Jan 26, 2025 A- ST-3 Stable Jan 25, 2026 Alpha Credit Rating Limited Feb 26, 2024 A- ST-3 Stable Jan 25, 2025 Alpha Credit Rating Limited         Half Year End (HY) Information  202512 HY Net Turnover(mn)  238.96 HY Net Profit after tax(mn)  22.18 HY EPS  0.24  AGM Information   AGM Date  31 December, 2025 Record Date  20 November, 2025 Dividend(%)  0.50 (Cash only for general shareholders excluding Sponsors and Directors-June 2025) Bonus Issue  2%-2021, 10%-2019,10%-2018

   

Interim Financial Performance: 2026
Particulars	Unaudited / Audited
	Q1	Q2	Half Yearly	Q3	9 Months	Annual
	Ending on	Ending on	6 Months	Ending on		Ending on
	30-Sep-2025	31-Dec-2025	31-Dec-2025	31-Mar-2026		30-Jun-2026
Earnings Per Share (EPS)
Basic	0.150	0.090	0.240	0.090	0.330
Diluted*
Earnings Per Share (EPS) - continuing operations
Basic	0.150	0.090	0.240	0.090	0.330
Diluted*
Market price per share at period end

*As per BSEC Directive No. SEC/CMRRCD/2009-193/64, dated September 21, 2010.

*Note: For detail financial statements, please visit company’s website.

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2025	0.72	0	0	0	16.43	0	66.87	0	0.50%C	0.37
2024	0.9	0	0	0	15.78	0	83.99	0	1%C	0.39
2023	1.06	0	0	0	15.02	0	98.64	0	2%C	0.76
2022	1.05	0	0	0	14.1	0	97.53	0	2%C	0.8
2021	1.24	0	0	0	13.52	0	113.59	0	2%C,2%B	0.8

Financial Statements
Quarterly Financial Statement	https://www.adventpharmabd.com/quarterly-reports/
Price Sensitive Information	https://www.adventpharmabd.com/price-sensitive-information/

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To